Study shows melanized nanoparticles' capability in radiation protection

04/28/2010 | HealthImaging.com

Researchers discovered that routine injection of melanin-coated nanoparticles into the bone marrow of mice can reduce the hematologic toxicity associated with external radiation or radioimmunotherapy. The technique might allow doctors to use more extensive cancer-eliminating radiation that could lead to a higher tumor-response rate, a researcher said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park